Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab Reports NDA Acceptance Of Sulbactam-Durlobactam (SUL-DUR) For Infections Caused By Acinetobacter Baumannii In China By NMPA

Feb 22 (Reuters) - Zai Lab Ltd  9688.HK :
    * ZAI LAB LTD: NDA ACCEPTANCE OF SULBACTAM-DURLOBACTAM
(SUL-DUR)
FOR INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII IN CHINA BY
NMPA

Source text for Eikon:  ID:nGNX41c9hL 
Further company coverage:  9688.HK 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zai Lab

See all news